세계의 감염성 질환 시장(2025-2029년)

The infectious disease market is forecasted to grow by USD 160.8 billion during 2024-2029, accelerating at a CAGR of 14.7% during the forecast period. The report on the infectious disease market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of infectious diseases, growing awareness of infectious diseases, and strong drug pipeline.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's infectious disease market is segmented as below:

By Product

• Drugs
• Vaccines

By End-user

• Hospital
• Multispecialty clinic
• Others

By Type

• Bacterial infections
• Viral infections
• Fungal infections
• Parasitic infections

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the development of novel drugs as one of the prime reasons driving the infectious disease market growth during the next few years. Also, increasing mergers and acquisitions and emergence of new patterns of infectious diseases will lead to sizable demand in the market.

The report on the infectious disease market covers the following areas:

• Infectious Disease Market sizing
• Infectious Disease Market forecast
• Infectious Disease Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading infectious disease market vendors that include Abbott Laboratories, Becton Dickinson and Co., Bio RAD Laboratories Inc., BioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., Perkin Elmer Inc., QIAGEN N.V., QuidelOrtho Corp., Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Trinity Biotech PLC. Also, the infectious disease market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Global - Market size and forecast 2024-2029 ($ billion)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Infectious Disease Market 2019 - 2023
  • Historic Market Size - Data Table on Global Infectious Disease Market 2019 - 2023 ($ billion)
• 5.2 Product segment analysis 2019 - 2023
  • Historic Market Size - Product Segment 2019 - 2023 ($ billion)
• 5.3 End-user segment analysis 2019 - 2023
  • Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
• 5.4 Type segment analysis 2019 - 2023
  • Historic Market Size - Type Segment 2019 - 2023 ($ billion)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ billion)

6 Qualitative Analysis

• 6.1 Impact of AI on the global infectious disease market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

• 8.1 Market segments
  • Chart on Product - Market share 2024-2029 (%)
  • Data Table on Product - Market share 2024-2029 (%)
• 8.2 Comparison by Product
  • Chart on Comparison by Product
  • Data Table on Comparison by Product
• 8.3 Drugs - Market size and forecast 2024-2029
  • Chart on Drugs - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Drugs - Market size and forecast 2024-2029 ($ billion)
  • Chart on Drugs - Year-over-year growth 2024-2029 (%)
  • Data Table on Drugs - Year-over-year growth 2024-2029 (%)
• 8.4 Vaccines - Market size and forecast 2024-2029
  • Chart on Vaccines - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Vaccines - Market size and forecast 2024-2029 ($ billion)
  • Chart on Vaccines - Year-over-year growth 2024-2029 (%)
  • Data Table on Vaccines - Year-over-year growth 2024-2029 (%)
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ billion)
  • Data Table on Market opportunity by Product ($ billion)

9 Market Segmentation by End-user

• 9.1 Market segments
  • Chart on End-user - Market share 2024-2029 (%)
  • Data Table on End-user - Market share 2024-2029 (%)
• 9.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
• 9.3 Hospital - Market size and forecast 2024-2029
  • Chart on Hospital - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Hospital - Market size and forecast 2024-2029 ($ billion)
  • Chart on Hospital - Year-over-year growth 2024-2029 (%)
  • Data Table on Hospital - Year-over-year growth 2024-2029 (%)
• 9.4 Multispecialty clinic - Market size and forecast 2024-2029
  • Chart on Multispecialty clinic - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Multispecialty clinic - Market size and forecast 2024-2029 ($ billion)
  • Chart on Multispecialty clinic - Year-over-year growth 2024-2029 (%)
  • Data Table on Multispecialty clinic - Year-over-year growth 2024-2029 (%)
• 9.5 Others - Market size and forecast 2024-2029
  • Chart on Others - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Others - Market size and forecast 2024-2029 ($ billion)
  • Chart on Others - Year-over-year growth 2024-2029 (%)
  • Data Table on Others - Year-over-year growth 2024-2029 (%)
• 9.6 Market opportunity by End-user
  • Market opportunity by End-user ($ billion)
  • Data Table on Market opportunity by End-user ($ billion)

10 Market Segmentation by Type

• 10.1 Market segments
  • Chart on Type - Market share 2024-2029 (%)
  • Data Table on Type - Market share 2024-2029 (%)
• 10.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 10.3 Bacterial infections - Market size and forecast 2024-2029
  • Chart on Bacterial infections - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Bacterial infections - Market size and forecast 2024-2029 ($ billion)
  • Chart on Bacterial infections - Year-over-year growth 2024-2029 (%)
  • Data Table on Bacterial infections - Year-over-year growth 2024-2029 (%)
• 10.4 Viral infections - Market size and forecast 2024-2029
  • Chart on Viral infections - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Viral infections - Market size and forecast 2024-2029 ($ billion)
  • Chart on Viral infections - Year-over-year growth 2024-2029 (%)
  • Data Table on Viral infections - Year-over-year growth 2024-2029 (%)
• 10.5 Fungal infections - Market size and forecast 2024-2029
  • Chart on Fungal infections - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Fungal infections - Market size and forecast 2024-2029 ($ billion)
  • Chart on Fungal infections - Year-over-year growth 2024-2029 (%)
  • Data Table on Fungal infections - Year-over-year growth 2024-2029 (%)
• 10.6 Parasitic infections - Market size and forecast 2024-2029
  • Chart on Parasitic infections - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Parasitic infections - Market size and forecast 2024-2029 ($ billion)
  • Chart on Parasitic infections - Year-over-year growth 2024-2029 (%)
  • Data Table on Parasitic infections - Year-over-year growth 2024-2029 (%)
• 10.7 Market opportunity by Type
  • Market opportunity by Type ($ billion)
  • Data Table on Market opportunity by Type ($ billion)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 12.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ billion)
  • Data Table on North America - Market size and forecast 2024-2029 ($ billion)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 12.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 12.5 Asia - Market size and forecast 2024-2029
  • Chart on Asia - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
  • Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Data Table on Asia - Year-over-year growth 2024-2029 (%)
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
  • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• 12.7 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ billion)
  • Data Table on US - Market size and forecast 2024-2029 ($ billion)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 12.8 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 12.9 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ billion)
  • Data Table on UK - Market size and forecast 2024-2029 ($ billion)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 12.10 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ billion)
  • Data Table on China - Market size and forecast 2024-2029 ($ billion)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 12.11 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 12.12 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 12.13 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ billion)
  • Data Table on France - Market size and forecast 2024-2029 ($ billion)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 12.14 Italy - Market size and forecast 2024-2029
  • Chart on Italy - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
  • Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Data Table on Italy - Year-over-year growth 2024-2029 (%)
• 12.15 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ billion)
  • Data Table on India - Market size and forecast 2024-2029 ($ billion)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 12.16 The Netherlands - Market size and forecast 2024-2029
  • Chart on The Netherlands - Market size and forecast 2024-2029 ($ billion)
  • Data Table on The Netherlands - Market size and forecast 2024-2029 ($ billion)
  • Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
  • Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
• 12.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ billion)
  • Data Tables on Market opportunity By Geographical Landscape ($ billion)

13 Drivers, Challenges, and Opportunity/Restraints

• 13.1 Market drivers
• 13.2 Market challenges
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities/restraints

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Market positioning of companies
  • Matrix on companies position and classification
• 15.3 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key offerings
• 15.4 Gilead Sciences, Inc.
  • Gilead Sciences, Inc. - Overview
  • Gilead Sciences, Inc. - Product / Service
  • Gilead Sciences, Inc. - Key offerings
• 15.5 GlaxoSmithKline plc (GSK)
  • GlaxoSmithKline plc (GSK) - Overview
  • GlaxoSmithKline plc (GSK) - Product / Service
  • GlaxoSmithKline plc (GSK) - Key offerings
• 15.6 Merck & Co., Inc.
  • Merck & Co., Inc. - Overview
  • Merck & Co., Inc. - Product / Service
  • Merck & Co., Inc. - Key offerings
• 15.7 Johnson & Johnson
  • Johnson & Johnson - Overview
  • Johnson & Johnson - Product / Service
  • Johnson & Johnson - Key offerings
• 15.8 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key offerings
• 15.9 Sanofi S.A.
  • Sanofi S.A. - Overview
  • Sanofi S.A. - Product / Service
  • Sanofi S.A. - Key offerings
• 15.10 AstraZeneca plc
  • AstraZeneca plc - Overview
  • AstraZeneca plc - Product / Service
  • AstraZeneca plc - Key offerings
• 15.11 BioNTech SE
  • BioNTech SE - Overview
  • BioNTech SE - Product / Service
  • BioNTech SE - Key offerings
• 15.12 Novartis International AG
  • Novartis International AG - Overview
  • Novartis International AG - Product / Service
  • Novartis International AG - Key offerings
• 15.13 Hoffmann-La Roche AG
  • Hoffmann-La Roche AG - Overview
  • Hoffmann-La Roche AG - Product / Service
  • Hoffmann-La Roche AG - Key offerings
• 15.14 Bristol-Myers Squibb Company
  • Bristol-Myers Squibb Company - Overview
  • Bristol-Myers Squibb Company - Product / Service
  • Bristol-Myers Squibb Company - Key offerings
• 15.15 Eli Lilly and Company
  • Eli Lilly and Company - Overview
  • Eli Lilly and Company - Product / Service
  • Eli Lilly and Company - Key offerings
• 15.16 Takeda Pharmaceutical Co. Ltd
  • Takeda Pharmaceutical Co. Ltd - Overview
  • Takeda Pharmaceutical Co. Ltd - Product / Service
  • Takeda Pharmaceutical Co. Ltd - Key offerings
• 15.17 Boehringer Ingelheim GmbH
  • Boehringer Ingelheim GmbH - Overview
  • Boehringer Ingelheim GmbH - Product / Service
  • Boehringer Ingelheim GmbH - Key offerings
• 15.18 Mylan N.V.
  • Mylan N.V. - Overview
  • Mylan N.V. - Product / Service
  • Mylan N.V. - Key offerings
• 15.19 CSL Limited
  • CSL Limited - Overview
  • CSL Limited - Product / Service
  • CSL Limited - Key offerings
• 15.20 Amgen Inc.
  • Amgen Inc. - Overview
  • Amgen Inc. - Product / Service
  • Amgen Inc. - Key offerings
• 15.21 Bayer AG
  • Bayer AG - Overview
  • Bayer AG - Product / Service
  • Bayer AG - Key offerings
• 15.22 Moderna, Inc.
  • Moderna, Inc. - Overview
  • Moderna, Inc. - Product / Service
  • Moderna, Inc. - Key offerings

16 Appendix

• 16.1 Scope of the report
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations